Cargando…
Epigenetics of cutaneous T-cell lymphoma: biomarkers and therapeutic potentials
Cutaneous T-cell lymphomas (CTCLs) are a heterogeneous group of skin-homing non-Hodgkin lymphomas. There are limited options for effective treatment of patients with advanced-stage CTCL, leading to a poor survival rate. Epigenetics plays a pivotal role in regulating gene expression without altering...
Autores principales: | Lai, Pan, Wang, Yang |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Compuscript
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7877166/ https://www.ncbi.nlm.nih.gov/pubmed/33628583 http://dx.doi.org/10.20892/j.issn.2095-3941.2020.0216 |
Ejemplares similares
-
Epigenetics of Cutaneous T-Cell Lymphomas
por: Hara, Natsumi, et al.
Publicado: (2022) -
Novel therapeutic agents for cutaneous T-Cell lymphoma
por: Jain, Salvia, et al.
Publicado: (2012) -
Epigenetics in the Pathogenesis and Treatment of Cutaneous T-Cell Lymphoma
por: Zhang, Ping, et al.
Publicado: (2021) -
Proteomic Approaches to Biomarker Discovery in Cutaneous T-Cell Lymphoma
por: Ion, Alexandra, et al.
Publicado: (2016) -
Epigenetic aberrations in natural killer/T-cell lymphoma: diagnostic, prognostic and therapeutic implications
por: Küçük, Can, et al.
Publicado: (2020)